Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06486922 · ClinicalTrials.gov registry record · NA
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development Trial
A NA study of Breastfeeding and Nutrition, Healthy, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06486922: Recruiting NA study of Breastfeeding and Nutrition, Healthy, sponsored by Northwell Health.
NCT06486922 is a NA study of Breastfeeding and Nutrition, Healthy that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 40 participants, below the 596-participant average among 36 other Breastfeeding trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06486922, a NA study of Breastfeeding and Nutrition, Healthy, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this intervention development study is to optimize the Starting Early to Prevent Obesity Using Telehealth (StEP OUT) intervention for feasibility and acceptability, using human-centered design and community-engaged research methods.
Primary Outcome
We will use the Sekhon acceptability framework to assess affective attitude, burden, opportunity cost, perceived effectiveness, coherence, ethicality, self-efficacy and general acceptability.
Conditions Studied
Interventions
- BEHAVIORAL StEP OUT
Study Locations (1)
New York
- Long Island Jewish Medical Center - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-10 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
What NCT06486922 shows while recruiting
NCT06486922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 596-participant average among 36 other Breastfeeding trials with a reported enrollment target (93% lower).
The record links to 4 conditions, with Breastfeeding appearing as the primary indexed condition, and to 1 intervention - of which StEP OUT is the first listed.
NCT06486922 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06486922 about?
NCT06486922 is a clinical study titled "Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Intervention Development Trial". The goal of this intervention development study is to optimize the Starting Early to Prevent Obesity Using Telehealth (StEP OUT) intervention for feasibility and acceptability, using human-centered design and community-engaged research methods.
What is the current status of trial NCT06486922?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-10. Estimated completion is 2026-12-30.
What conditions does trial NCT06486922 study?
This clinical trial studies the following conditions: Breastfeeding, Nutrition, Healthy, Child Obesity, Feeding Behavior.
What interventions are being tested in trial NCT06486922?
The interventions under investigation include: StEP OUT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06486922?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06486922 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06486922's enrollment target sits among peer trials
40 29th of 36 higher than 4 of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)
RECRUITING · NA
-
Development of the Couplet Care Bassinet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI